Security key
881624209
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 686,977,855
- Total 13F value
- $21,442,593,594
- Share change
- +30,154,486
- Put/Call ratio
- 62%
- SEC-reported price per share
- $31.21
- Number of holders
- 628
- Value change
- +$1,230,700,950
- Number of buys
- 309
- Number of sells
- 231
- Shares outstanding
- 1,148,777,709
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
628
Top holders
10
TEVA full security history
Ownership snapshot
Full 13F holder table
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Harel Insurance Investmen...
Disclosed value leader
Migdal Insurance & Financ...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F
13D/G
Lead comparable stake: 6.3%
13D/G row: Harel Insurance Investments & Financial Services Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Harel Insurance Investments & Financial Services Ltd. leads the comparable SEC ownership view at 6.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Harel Insurance Investments & Financial Services Ltd.'s linked filing trail.
Comparable ownership
Top 5
Harel Insurance Investments & Fin...
6.3%
Migdal Insurance & Financial Hold...
5.4%
MENORA MIVTACHIM HOLDINGS LTD.
5%
Phoenix Financial Ltd.
5%
FMR LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. |
13F
13D/G
Company
|
6.3%
from 13D/G
|
$761,455,000
37,696,690 shares
|
— | 30 Sep 2025 |
| Migdal Insurance & Financial Holdings Ltd. |
13D/G
13F
Company
|
5.4%
|
$2,022,794,213
61,689,363 shares
|
$0 | 31 Dec 2025 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13D/G
13F
Company
|
5%
|
$961,943,099
57,395,173 shares
|
$0 | 16 Jul 2025 |
| Phoenix Financial Ltd. |
13D/G
13F
Company
|
5%
|
$961,741,722
57,383,158 shares
|
$0 | 14 Jul 2025 |
| FMR LLC |
13F
13D/G
Company
|
2.1%
from 13D/G
|
$497,755,500
24,641,362 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
5%
|
$1,167,608,637
57,802,408 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
628
Shares
686,977,855
Rows available
628
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
544
Q4 2025 holders
628
Holder diff
84
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|